Rpa2 rpa32

Manufactured by Cell Signaling Technology

RPA2/RPA32 is a laboratory reagent that detects the RPA2/RPA32 protein, a subunit of the Replication Protein A (RPA) complex. RPA is a heterotrimeric protein complex that plays a crucial role in DNA replication, repair, and recombination processes. The RPA2/RPA32 product can be used to identify and quantify the RPA2/RPA32 protein in various experimental applications.

Automatically generated - may contain errors

Lab products found in correlation

γh2ax, by Cell Signaling Technology (2 mentions) Rpa2 rpa32 ser 33, by Cell Signaling Technology (2 mentions) Active caspase 3, by Cell Signaling Technology (1 mentions) C rel, by Santa Cruz Biotechnology (1 mentions) β actin, by Merck Group (1 mentions) C myc, by Santa Cruz Biotechnology (1 mentions) Cdc25b, by Cell Signaling Technology (1 mentions) Usp1 14346 1 ap, by Proteintech (1 mentions) Usp14, by Proteintech (1 mentions)

Spelling variants of this product

RPA32 (15 citations) P-RPA32/RPA2 (83745S) (2 citations) RPA2/RPA32 Ser 33 (2 citations)

2 protocols using rpa2 rpa32

Comprehensive Antibody Panel for DNA Damage Response

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antibodies used were c-Rel (sc-71 Santa Cruz), c-Myc (sc-42 Santa Cruz), ATR (sc1887 Santa Cruz), RelA (sc-372 Santa Cruz), RelB (4954 Cell Signaling), p105/p50 (ab7971 Abcam), p100/p52 (4882 Cell Signaling), β-Actin (A5441 Sigma), CHK1 (phospho S345) (2341 Cell Signaling), CHK1 (2360 Cell Signaling) RelA (phospho 536) (3031 Cell Signaling), active caspase 3 (9664 Cell Signaling), γH2AX (9718 Cell Signaling), RPA2/RPA32 Ser 33 (10148 Cell Signaling), RPA2/RPA32 (52488 Cell Signaling), ATRIP (11327-1-AP Proteintech), Rad17 (13358-1-AP Proteintech), ATR (13934 Cell Signaling), Karyopherin Beta (Santa Cruz sc-137016). Antibodies to the murine form of Claspin was generated by Moravian Biotechnologies. Anti-rabbit IgG (A6154 Sigma and 7074 Cell Signaling) and anti-mouse IgG (A9044 Sigma) HRP-linked secondary antibodies were used for western blot detection.

Hunter J.E., Campbell A.E., Butterworth J.A., Sellier H., Hannaway N.L., Luli S., Floudas A., Kenneth N.S., Moore A.J., Brownridge P.J., Thomas H.D., Coxhead J., Taylor L., Leary P., Hasoon M.S., Knight A.M., Garrett M.D., Collins I., Eyers C.E, & Perkins N.D. (2022). Mutation of the RelA(p65) Thr505 phosphosite disrupts the DNA replication stress response leading to CHK1 inhibitor resistance. Biochemical Journal, 479(19), 2087-2113.

+ Open protocol

+ Expand

Cellular Stress Response Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antibodies used were CHK1 (phospho S345) (2341 Cell Signaling), CHK1 (2360 Cell Signaling), USP1 (14346-1-AP Proteintech), USP14 (14517-1-AP Proteintech), γH2AX (2577 Cell Signaling), CDC25B (9525 Cell Signaling), CHK2 (3440 Cell Signaling), Karyopherin (sc-137016 Santa Cruz), CDK2 (2546 Cell Signaling), CDK1 (phospho Y15) (4539 Cell Signaling), RPA2/RPA32 Ser 33 (10148 Cell Signaling), RPA2/RPA32 (52488 Cell Signaling), ATRIP (11327-1-AP Proteintech), Rad17 (13358-1-AP Proteintech), ATR Ser 428 (2853 Cell Signaling), ATR (13934 Cell Signaling) and CDK1 (9116 Cell Signaling). Antibodies to the murine form of Claspin was generated by Moravian Biotechnologies. Anti-rabbit IgG (A6154 Sigma and 7074 Cell Signaling) and anti-mouse IgG (7076 Cell Signaling) HRP-linked secondary antibodies were used for western blot detection.

Hunter J.E., Campbell A.E., Hannaway N.L., Kerridge S., Luli S., Butterworth J.A., Sellier H., Mukherjee R., Dhillon N., Sudhindar P.D., Shukla R., Brownridge P.J., Bell H.L., Coxhead J., Taylor L., Leary P., Hasoon M.S., Collins I., Garrett M.D., Eyers C.E, & Perkins N.D. (2022). Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway. Biochemical Journal, 479(19), 2063-2086.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!